The Oncomine database demonstrated that mRNA expression of DHCR7 was significantly higher in various human cancers, including colorectal cancer, bladder cancer, breast cancer, head and neck cancer, and ovarian cancer, when compared to corresponding normal tissues. This evidence concerns the gene DHCR7 and breast cancer.